IBLHL logo

IBL HealthCare Limited IBLHL

Market closed

Rs 49.03

-0.74 (-1.49%)

Vol99,196Updated10:3029 Jul 2026

01At a Glance

The headline take on IBLHL — valuation, income, returns, and efficiency

Consolidated snapshot

IBL HealthCare Limited (IBLHL) is a Pharmaceuticals company listed on the Pakistan Stock Exchange. As of 29 Jul 2026, IBLHL last traded at Rs 49.03 (-1.49% on the day) with a market cap of Rs 4.83B and a free float of 25.0%. Over the last 12 months the stock has returned -21.9%. The stock trades at a P/E of 20.2x.

Prices through 29 Jul 2026 · FY data through FY25 · Quarterly through Mar-26

20.2x
Rs 2.43
1Y Return
-21.9%
Rs 4.83B

02Price & Performance

Closing prices across timeframes, returns, and range context

IBLHL — Price History

Daily closing series · toggle period below

1M Return-7.5%
3M Return-2.4%
6M Return-20.9%
1Y Return-21.9%
Day's Range21% of range
Rs 49.03
LowRs 48.80
HighRs 49.90
52-Week Range26% of range
Rs 49.03
LowRs 36.00
HighRs 85.82

03Key Metrics

Valuation, profitability, structure, and risk in one grid

20.2xTrailing annual EPS
Rs 2.43Latest annual · basic
2.08xBook Rs 23.58
No recent payout
1.08Higher than market
Rs 4.83BSmall cap
25.0%25M shares
6.84Moderate leverage
9.4%Latest annual
Rs 10Per share

04Dividend History & Yield

Payout track record, yield trend, and upcoming distribution

IBLHL has no cash dividend in the trailing 12 months. Its most recent payout was a 15% bonus issue, announced 01 Oct 2025 with book closure from 09 Oct 2025. Annual dividend-per-share history back to 2016 is charted below.

Latest Payout

Per Share
15% (Bonus)
Yield (last FY)
Payout Ratio
Announced
01 Oct 2025

Dividend Per Share Trend

2021
Rs 0.63
2022
Rs 0.76
2023
Rs 0.00
2024
Rs 0.00
2025
Rs 0.00

Payout History

Source: PSX company payouts

AnnouncedFor PeriodTypeAmountBook Closure
01 Oct 202530 Jun 2025 (YR)Bonus15%09 Oct 2025 – 09 Oct 2025

05Financials & Earnings

Income, balance sheet, and key ratios from published accounts

IBLHL's market capitalisation stands at Rs 4.83B as of 29 Jul 2026 down 20.9% over the past 12 months (from Rs 6.11B).

Financial Statements

How OGDC's income and balance sheet have evolved

PKR MillionsFY25FY24FY23FY22FY21FY20Trend
Net Sales / Revenue4,3223,6034,0283,6513,0042,665
Cost of Sales2,8752,6522,6872,3951,9811,853
Gross Profit1,4479511,3411,2561,022811
Administrative Expenses144104100959285
Operating Profit445153610579413299
EBITDA453161617586419304
Other Income032-85-603254
Financial Charges606766273031
Profit Before Tax377108459483409322
Taxation169100150180109102
Profit After Tax2088309303300220
EPS - Basic (Rs)Rs 2.43Rs 0.09Rs 3.61Rs 3.53Rs 3.51Rs 2.57

All figures in PKR millions from published accounts.

Profitability & Returns

Margins, returns on capital, and earnings per share

Latest · FY25

RatioValue
Net profit margin4.8%
Gross profit margin33.5%
EBITDA margin10.5%
EBIT margin10.3%

Net profit margin

Net profit ÷ revenue · %

0.0%2.5%5.0%7.5%10.0%8.3%FY2010.0%FY218.3%FY227.7%FY230.2%FY244.8%FY25Period
Earlier periodsLatest period

Financial Health

Coverage, leverage, and the strength of the balance sheet

Latest · FY25

RatioValue
Effective tax rate44.8%

Effective tax rate

Taxation ÷ profit before tax · %

0.0%23.1%46.3%69.4%92.6%31.7%FY2026.7%FY2137.3%FY2232.7%FY2392.6%FY2444.8%FY25Period
Earlier periodsLatest period

Market cap trajectory

Close × current shares outstanding · current Rs 4.83B

Rs 7.91BRs 5.57BRs 3.23BRs 891.23MJul 25Sept 25Nov 25Jan 26Mar 26May 26Rs 4.83B

Valuation & Capital Returns

What the market is paying for IBLHL, and what it returns to shareholders

Latest · FY25

RatioValue
Price to earnings26.32x
Price to sales1.46x

Price to earnings

Period-end price ÷ EPS · times

0.00x114.47x228.94x343.42x457.89x44.86xFY2019.97xFY2110.65xFY2210.03xFY23457.89xFY2426.32xFY25Period
Earlier periodsLatest period

06Technical Analysis

Trading signal, moving averages, momentum, and key levels

Trading Signal
SELL

10-day SMA (Rs 49.84) is below the 30-day SMA (Rs 52.78). RSI at 43 sits in the neutral band.

As of29 Jul 2026

PeriodValuevs CurrentPosition
SMA 10Rs 49.84+1.65%Below
SMA 30Rs 52.78+7.64%Below
SMA 60Rs 50.24+2.48%Below
SMA 200Rs 52.84+7.76%Below
43Neutral
0 · Oversold305070100 · Overbought

At 43, momentum sits within the neutral band (30–70), suggesting balanced buying and selling pressure.

MACD
Bearish Cross
  • MACD-0.96
  • Signal-0.45
  • Histogram-0.51
R2Resistance 2
Rs 66.74
36.1%
R1Resistance 1
Rs 57.88
18.1%
NOWCurrent
Rs 49.03
S1Support 1
Rs 42.69
-12.9%
S2Support 2
Rs 36.36
-25.8%

07Leverage Insights

MTS, margin financing, futures open interest, and combined exposure

Not MTS-eligible
Rs 25.60M
-55.45% MoMMargin financing
Rs 25.60M
-55.45% MoMMTS + MFS combined

Leverage Composition

MTS · MFS stacked over the selected window

No blank sales

No net blank (short) sales reported for IBLHL on the latest PSX DFC report.

08Settlement Insights

UIN-wise settlement concentration and price context

Metrics and charts over the selected trailing window

Latest UIN %88.31%Most recent print
Average · 3M67.23%Mean over window
Change · 3M+55.23%First → last
Range · 3M18.3–94.9%Low–high

Settlement % Trajectory

Solid = UIN settlement % · Dashed = 14-session EMA

As of 16 Jul 2026

Price vs Settlement

Close price (left axis) · UIN settlement % (right axis)

09Share Structure & Capital

Float composition, capital base, and enterprise value

Free float · 25.0%Non-float · 75.0%

Free float vs locked-in holdings

Paid-Up CapitalRs 985.26M
Total Shares99M
25M
25.0%
Year EndJun
Enterprise Value

10About the Company

Business description, governance, and corporate information

IBL HealthCare Limited was incorporated in Pakistan under the repealed Companies Ordinance, 1984 (now the Companies Act, 2017) as a private limited company on July 14, 1997. In November 2008, the Company was converted into public limited company. The principal activities of the Company include marketing, selling and distribution of healthcare products.

Shariah CompliantPharmaceuticals

Corporate Information

  • RegistrarCenteral Depository Co of Pakistan. CDC House 99 B, Block B S.M.C.H.S, Main Shahrah e Faisal Karachi.
  • AuditorA.F.Fergusons & Co, Chartered Accountants
  • Websitewww.iblhc.com
  • Address2nd Floor, One IBL Centre, Block 7&8, DMCHS Tipu Sultan Road, Off: Shahrah-e-Faisal, Karachi
  • SectorPharmaceuticals
  • Financial Year EndJune

Key People

NameRole
SKSheraz Khan
CEO
MZMufti Zia ul Islam
Chairperson
HMHussain Murtaza
Company Secretary

11Recent Announcements

Latest company filings as reported on PSX

Filings and disclosures from the PSX announcement feed

12Peers in Pharmaceuticals

How the cohort is moving — same-sector stocks by market cap

IBLHL vs Pharmaceuticals sector median

Median across 14 sector constituents · nulls excluded per metric

MetricIBLHLSector median
20.2x16.0x
0.0%4.0%
9.4%22.3%
1-Year Return-21.9%-8.7%
Rs 4.83BRs 27.79B

13Frequently Asked Questions

The most common questions investors ask about IBLHL

Frequently Asked Questions

IBLHL closed at Rs 49.03 on 29 Jul 2026, down 1.49% on the day, within a 52-week range of Rs 36.00–85.82. Prices on this page refresh through the trading day; log in to BSL for live quotes.

Ready to invest in IBLHL?

Open a BSL trading account in under 10 minutes

Buy and sell IBLHL and 550+ other PSX-listed stocks with low commissions, real-time data, and a concierge research desk backing every trade.

Open Account